Drug-Induced Acute Kidney Injury (DIAKI) can be classified in type A reactions, in which the mechanism of aggression is explained by the drug pharmacology (time of use and dose) and in type B reactions, when the nephrotoxicity can not be predictable and depends on drug pharmacogenetics and corresponds to Acute Interstitial Nephritis (AIN), crystalline nephropathy and tubular diseases (Bartterlike or Gitelman-like). This study aimed to determine the incidence of DIAKI, the associated drugs, its phenotypes and the main prognostic factors.
No takes yet. Share an insight, caveat, or question.
Ponce et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: